nodes	percent_of_prediction	percent_of_DWPC	metapath
Nilutamide—AR—semen—hepatitis B	0.0406	0.321	CbGeAlD
Nilutamide—Cough increased—Adefovir Dipivoxil—hepatitis B	0.0242	0.0292	CcSEcCtD
Nilutamide—Creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0233	0.0281	CcSEcCtD
Nilutamide—Bone pain—Adefovir Dipivoxil—hepatitis B	0.0231	0.0279	CcSEcCtD
Nilutamide—Blood creatinine increased—Entecavir—hepatitis B	0.0154	0.0187	CcSEcCtD
Nilutamide—Blood creatinine increased—Adefovir Dipivoxil—hepatitis B	0.0151	0.0182	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Adefovir Dipivoxil—hepatitis B	0.0142	0.0171	CcSEcCtD
Nilutamide—CYP2C19—blood plasma—hepatitis B	0.0137	0.108	CbGeAlD
Nilutamide—Upper respiratory tract infection—Entecavir—hepatitis B	0.0132	0.016	CcSEcCtD
Nilutamide—Hyperglycaemia—Entecavir—hepatitis B	0.0129	0.0155	CcSEcCtD
Nilutamide—Weight decreased—Adefovir Dipivoxil—hepatitis B	0.0126	0.0152	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Telbivudine—hepatitis B	0.0122	0.0147	CcSEcCtD
Nilutamide—Haematuria—Entecavir—hepatitis B	0.0121	0.0146	CcSEcCtD
Nilutamide—CYP2C8—blood plasma—hepatitis B	0.012	0.0945	CbGeAlD
Nilutamide—Alanine aminotransferase increased—Telbivudine—hepatitis B	0.0119	0.0144	CcSEcCtD
Nilutamide—Haematuria—Adefovir Dipivoxil—hepatitis B	0.0118	0.0143	CcSEcCtD
Nilutamide—Influenza—Telbivudine—hepatitis B	0.0117	0.0141	CcSEcCtD
Nilutamide—Oedema peripheral—Entecavir—hepatitis B	0.0112	0.0136	CcSEcCtD
Nilutamide—Urinary tract disorder—Adefovir Dipivoxil—hepatitis B	0.011	0.0133	CcSEcCtD
Nilutamide—Urethral disorder—Adefovir Dipivoxil—hepatitis B	0.0109	0.0132	CcSEcCtD
Nilutamide—Upper respiratory tract infection—Telbivudine—hepatitis B	0.0109	0.0131	CcSEcCtD
Nilutamide—CYP2C9—blood plasma—hepatitis B	0.0106	0.084	CbGeAlD
Nilutamide—Alopecia—Entecavir—hepatitis B	0.0101	0.0122	CcSEcCtD
Nilutamide—Photophobia—Lamivudine—hepatitis B	0.00987	0.0119	CcSEcCtD
Nilutamide—Gynaecomastia—Lamivudine—hepatitis B	0.00941	0.0114	CcSEcCtD
Nilutamide—Back pain—Adefovir Dipivoxil—hepatitis B	0.00937	0.0113	CcSEcCtD
Nilutamide—Hypoaesthesia—Telbivudine—hepatitis B	0.00932	0.0113	CcSEcCtD
Nilutamide—POR—blood—hepatitis B	0.00918	0.0725	CbGeAlD
Nilutamide—Anaemia—Adefovir Dipivoxil—hepatitis B	0.00895	0.0108	CcSEcCtD
Nilutamide—Leukopenia—Entecavir—hepatitis B	0.00889	0.0107	CcSEcCtD
Nilutamide—Cough—Adefovir Dipivoxil—hepatitis B	0.00845	0.0102	CcSEcCtD
Nilutamide—Chest pain—Adefovir Dipivoxil—hepatitis B	0.00825	0.00996	CcSEcCtD
Nilutamide—Back pain—Telbivudine—hepatitis B	0.00789	0.00953	CcSEcCtD
Nilutamide—Ill-defined disorder—Telbivudine—hepatitis B	0.00757	0.00914	CcSEcCtD
Nilutamide—Anorexia—Adefovir Dipivoxil—hepatitis B	0.00754	0.00911	CcSEcCtD
Nilutamide—Malaise—Telbivudine—hepatitis B	0.00736	0.00889	CcSEcCtD
Nilutamide—Insomnia—Entecavir—hepatitis B	0.00733	0.00885	CcSEcCtD
Nilutamide—POR—liver—hepatitis B	0.00718	0.0567	CbGeAlD
Nilutamide—Dyspepsia—Entecavir—hepatitis B	0.00713	0.00862	CcSEcCtD
Nilutamide—Cough—Telbivudine—hepatitis B	0.00712	0.0086	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Entecavir—hepatitis B	0.007	0.00845	CcSEcCtD
Nilutamide—Dyspepsia—Adefovir Dipivoxil—hepatitis B	0.00696	0.00841	CcSEcCtD
Nilutamide—Chest pain—Telbivudine—hepatitis B	0.00694	0.00839	CcSEcCtD
Nilutamide—Aspartate aminotransferase increased—Lamivudine—hepatitis B	0.00687	0.0083	CcSEcCtD
Nilutamide—Decreased appetite—Adefovir Dipivoxil—hepatitis B	0.00687	0.0083	CcSEcCtD
Nilutamide—Discomfort—Telbivudine—hepatitis B	0.00686	0.00829	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Adefovir Dipivoxil—hepatitis B	0.00683	0.00825	CcSEcCtD
Nilutamide—Alanine aminotransferase increased—Lamivudine—hepatitis B	0.00673	0.00813	CcSEcCtD
Nilutamide—Gastrointestinal pain—Entecavir—hepatitis B	0.00663	0.00801	CcSEcCtD
Nilutamide—Influenza—Lamivudine—hepatitis B	0.0066	0.00797	CcSEcCtD
Nilutamide—Gastrointestinal pain—Adefovir Dipivoxil—hepatitis B	0.00646	0.00781	CcSEcCtD
Nilutamide—Body temperature increased—Entecavir—hepatitis B	0.00641	0.00774	CcSEcCtD
Nilutamide—Abdominal pain—Entecavir—hepatitis B	0.00641	0.00774	CcSEcCtD
Nilutamide—Abdominal pain—Adefovir Dipivoxil—hepatitis B	0.00625	0.00755	CcSEcCtD
Nilutamide—Body temperature increased—Adefovir Dipivoxil—hepatitis B	0.00625	0.00755	CcSEcCtD
Nilutamide—Insomnia—Telbivudine—hepatitis B	0.00602	0.00727	CcSEcCtD
Nilutamide—Paraesthesia—Telbivudine—hepatitis B	0.00598	0.00722	CcSEcCtD
Nilutamide—Hyperglycaemia—Lamivudine—hepatitis B	0.00595	0.00719	CcSEcCtD
Nilutamide—Depression—Lamivudine—hepatitis B	0.00586	0.00709	CcSEcCtD
Nilutamide—Dyspepsia—Telbivudine—hepatitis B	0.00586	0.00708	CcSEcCtD
Nilutamide—Enzalutamide—ALB—hepatitis B	0.00586	1	CrCbGaD
Nilutamide—Asthenia—Entecavir—hepatitis B	0.00581	0.00702	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Telbivudine—hepatitis B	0.00575	0.00694	CcSEcCtD
Nilutamide—Pain—Telbivudine—hepatitis B	0.00569	0.00688	CcSEcCtD
Nilutamide—Asthenia—Adefovir Dipivoxil—hepatitis B	0.00567	0.00685	CcSEcCtD
Nilutamide—Sweating—Lamivudine—hepatitis B	0.00564	0.00681	CcSEcCtD
Nilutamide—Pruritus—Adefovir Dipivoxil—hepatitis B	0.00559	0.00676	CcSEcCtD
Nilutamide—Diarrhoea—Entecavir—hepatitis B	0.00554	0.0067	CcSEcCtD
Nilutamide—Feeling abnormal—Telbivudine—hepatitis B	0.00549	0.00663	CcSEcCtD
Nilutamide—Gastrointestinal pain—Telbivudine—hepatitis B	0.00544	0.00658	CcSEcCtD
Nilutamide—AR—blood—hepatitis B	0.00542	0.0428	CbGeAlD
Nilutamide—Diarrhoea—Adefovir Dipivoxil—hepatitis B	0.00541	0.00654	CcSEcCtD
Nilutamide—Dizziness—Entecavir—hepatitis B	0.00536	0.00647	CcSEcCtD
Nilutamide—Rhinitis—Lamivudine—hepatitis B	0.00529	0.0064	CcSEcCtD
Nilutamide—Abdominal pain—Telbivudine—hepatitis B	0.00526	0.00636	CcSEcCtD
Nilutamide—Body temperature increased—Telbivudine—hepatitis B	0.00526	0.00636	CcSEcCtD
Nilutamide—Hypoaesthesia—Lamivudine—hepatitis B	0.00525	0.00635	CcSEcCtD
Nilutamide—Vomiting—Entecavir—hepatitis B	0.00515	0.00622	CcSEcCtD
Nilutamide—Rash—Entecavir—hepatitis B	0.00511	0.00617	CcSEcCtD
Nilutamide—Dermatitis—Entecavir—hepatitis B	0.0051	0.00617	CcSEcCtD
Nilutamide—Headache—Entecavir—hepatitis B	0.00508	0.00613	CcSEcCtD
Nilutamide—Vomiting—Adefovir Dipivoxil—hepatitis B	0.00503	0.00607	CcSEcCtD
Nilutamide—CYP2C19—blood—hepatitis B	0.00503	0.0397	CbGeAlD
Nilutamide—Rash—Adefovir Dipivoxil—hepatitis B	0.00498	0.00602	CcSEcCtD
Nilutamide—Dermatitis—Adefovir Dipivoxil—hepatitis B	0.00498	0.00602	CcSEcCtD
Nilutamide—Headache—Adefovir Dipivoxil—hepatitis B	0.00495	0.00598	CcSEcCtD
Nilutamide—Nausea—Entecavir—hepatitis B	0.00481	0.00582	CcSEcCtD
Nilutamide—Asthenia—Telbivudine—hepatitis B	0.00478	0.00577	CcSEcCtD
Nilutamide—Pruritus—Telbivudine—hepatitis B	0.00471	0.00569	CcSEcCtD
Nilutamide—Nausea—Adefovir Dipivoxil—hepatitis B	0.0047	0.00567	CcSEcCtD
Nilutamide—Alopecia—Lamivudine—hepatitis B	0.00467	0.00564	CcSEcCtD
Nilutamide—Diarrhoea—Telbivudine—hepatitis B	0.00455	0.0055	CcSEcCtD
Nilutamide—Tension—Lamivudine—hepatitis B	0.00451	0.00545	CcSEcCtD
Nilutamide—Nervousness—Lamivudine—hepatitis B	0.00446	0.00539	CcSEcCtD
Nilutamide—Back pain—Lamivudine—hepatitis B	0.00445	0.00537	CcSEcCtD
Nilutamide—Dizziness—Telbivudine—hepatitis B	0.0044	0.00532	CcSEcCtD
Nilutamide—CYP2C8—blood—hepatitis B	0.00439	0.0346	CbGeAlD
Nilutamide—POR—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.00429	0.108	CbGpPWpGaD
Nilutamide—Ill-defined disorder—Lamivudine—hepatitis B	0.00426	0.00515	CcSEcCtD
Nilutamide—Anaemia—Lamivudine—hepatitis B	0.00425	0.00513	CcSEcCtD
Nilutamide—AR—liver—hepatitis B	0.00424	0.0335	CbGeAlD
Nilutamide—Vomiting—Telbivudine—hepatitis B	0.00423	0.00511	CcSEcCtD
Nilutamide—Rash—Telbivudine—hepatitis B	0.0042	0.00507	CcSEcCtD
Nilutamide—Dermatitis—Telbivudine—hepatitis B	0.00419	0.00507	CcSEcCtD
Nilutamide—Headache—Telbivudine—hepatitis B	0.00417	0.00504	CcSEcCtD
Nilutamide—Malaise—Lamivudine—hepatitis B	0.00415	0.00501	CcSEcCtD
Nilutamide—Syncope—Lamivudine—hepatitis B	0.00412	0.00498	CcSEcCtD
Nilutamide—Leukopenia—Lamivudine—hepatitis B	0.00411	0.00497	CcSEcCtD
Nilutamide—Loss of consciousness—Lamivudine—hepatitis B	0.00404	0.00488	CcSEcCtD
Nilutamide—Cough—Lamivudine—hepatitis B	0.00401	0.00485	CcSEcCtD
Nilutamide—Nausea—Telbivudine—hepatitis B	0.00395	0.00478	CcSEcCtD
Nilutamide—CYP2C19—liver—hepatitis B	0.00393	0.031	CbGeAlD
Nilutamide—Chest pain—Lamivudine—hepatitis B	0.00391	0.00473	CcSEcCtD
Nilutamide—CYP2C9—blood—hepatitis B	0.0039	0.0308	CbGeAlD
Nilutamide—Discomfort—Lamivudine—hepatitis B	0.00387	0.00467	CcSEcCtD
Nilutamide—Dry mouth—Lamivudine—hepatitis B	0.00383	0.00462	CcSEcCtD
Nilutamide—Oedema—Lamivudine—hepatitis B	0.00375	0.00453	CcSEcCtD
Nilutamide—Shock—Lamivudine—hepatitis B	0.00369	0.00446	CcSEcCtD
Nilutamide—Hyperhidrosis—Lamivudine—hepatitis B	0.00363	0.00438	CcSEcCtD
Nilutamide—Anorexia—Lamivudine—hepatitis B	0.00358	0.00432	CcSEcCtD
Nilutamide—CYP2C8—liver—hepatitis B	0.00343	0.0271	CbGeAlD
Nilutamide—Insomnia—Lamivudine—hepatitis B	0.00339	0.0041	CcSEcCtD
Nilutamide—Paraesthesia—Lamivudine—hepatitis B	0.00337	0.00407	CcSEcCtD
Nilutamide—Dyspnoea—Lamivudine—hepatitis B	0.00334	0.00404	CcSEcCtD
Nilutamide—Dyspepsia—Lamivudine—hepatitis B	0.0033	0.00399	CcSEcCtD
Nilutamide—Decreased appetite—Lamivudine—hepatitis B	0.00326	0.00394	CcSEcCtD
Nilutamide—Gastrointestinal disorder—Lamivudine—hepatitis B	0.00324	0.00391	CcSEcCtD
Nilutamide—Constipation—Lamivudine—hepatitis B	0.00321	0.00388	CcSEcCtD
Nilutamide—Pain—Lamivudine—hepatitis B	0.00321	0.00388	CcSEcCtD
Nilutamide—Feeling abnormal—Lamivudine—hepatitis B	0.00309	0.00373	CcSEcCtD
Nilutamide—Gastrointestinal pain—Lamivudine—hepatitis B	0.00307	0.00371	CcSEcCtD
Nilutamide—CYP2C9—liver—hepatitis B	0.00305	0.024	CbGeAlD
Nilutamide—Body temperature increased—Lamivudine—hepatitis B	0.00297	0.00358	CcSEcCtD
Nilutamide—Abdominal pain—Lamivudine—hepatitis B	0.00297	0.00358	CcSEcCtD
Nilutamide—Asthenia—Lamivudine—hepatitis B	0.00269	0.00325	CcSEcCtD
Nilutamide—Pruritus—Lamivudine—hepatitis B	0.00265	0.00321	CcSEcCtD
Nilutamide—Diarrhoea—Lamivudine—hepatitis B	0.00257	0.0031	CcSEcCtD
Nilutamide—Dizziness—Lamivudine—hepatitis B	0.00248	0.003	CcSEcCtD
Nilutamide—Vomiting—Lamivudine—hepatitis B	0.00239	0.00288	CcSEcCtD
Nilutamide—Rash—Lamivudine—hepatitis B	0.00237	0.00286	CcSEcCtD
Nilutamide—Dermatitis—Lamivudine—hepatitis B	0.00236	0.00286	CcSEcCtD
Nilutamide—Headache—Lamivudine—hepatitis B	0.00235	0.00284	CcSEcCtD
Nilutamide—Nausea—Lamivudine—hepatitis B	0.00223	0.00269	CcSEcCtD
Nilutamide—CYP2C8—CYP2E1 reactions—CYP2A6—hepatitis B	0.00178	0.0447	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—NR0B2—hepatitis B	0.00171	0.0429	CbGpPWpGaD
Nilutamide—CYP2C19—CYP2E1 reactions—CYP2A6—hepatitis B	0.00159	0.0399	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptors—HNF4A—hepatitis B	0.0015	0.0377	CbGpPWpGaD
Nilutamide—CYP2C9—CYP2E1 reactions—CYP2A6—hepatitis B	0.00145	0.0364	CbGpPWpGaD
Nilutamide—AR—Nuclear Receptor transcription pathway—HNF4A—hepatitis B	0.00118	0.0298	CbGpPWpGaD
Nilutamide—CYP2C8—Xenobiotics—CYP2A6—hepatitis B	0.0011	0.0277	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—NR0B2—hepatitis B	0.00109	0.0275	CbGpPWpGaD
Nilutamide—CYP2C8—Tamoxifen metabolism—CYP2A6—hepatitis B	0.00106	0.0266	CbGpPWpGaD
Nilutamide—CYP2C19—Xenobiotics—CYP2A6—hepatitis B	0.000983	0.0247	CbGpPWpGaD
Nilutamide—CYP2C19—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000945	0.0238	CbGpPWpGaD
Nilutamide—CYP2C9—Xenobiotics—CYP2A6—hepatitis B	0.000896	0.0225	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—APOBEC3G—hepatitis B	0.000889	0.0224	CbGpPWpGaD
Nilutamide—CYP2C9—Tamoxifen metabolism—CYP2A6—hepatitis B	0.000862	0.0217	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—HNF4A—hepatitis B	0.000818	0.0206	CbGpPWpGaD
Nilutamide—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000675	0.017	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—IFNB1—hepatitis B	0.000642	0.0161	CbGpPWpGaD
Nilutamide—CYP2C9—Constitutive Androstane Receptor Pathway—CYP2A6—hepatitis B	0.000615	0.0155	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—IL10—hepatitis B	0.000495	0.0125	CbGpPWpGaD
Nilutamide—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000457	0.0115	CbGpPWpGaD
Nilutamide—CYP2C8—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000451	0.0113	CbGpPWpGaD
Nilutamide—AR—Notch-mediated HES/HEY network—CD4—hepatitis B	0.000435	0.0109	CbGpPWpGaD
Nilutamide—CYP2C8—Arachidonic acid metabolism—GGT1—hepatitis B	0.000413	0.0104	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—HNF4A—hepatitis B	0.000412	0.0104	CbGpPWpGaD
Nilutamide—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000408	0.0103	CbGpPWpGaD
Nilutamide—CYP2C19—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000403	0.0101	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CDKN2A—hepatitis B	0.000375	0.00942	CbGpPWpGaD
Nilutamide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP2A6—hepatitis B	0.000372	0.00936	CbGpPWpGaD
Nilutamide—CYP2C8—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000371	0.00932	CbGpPWpGaD
Nilutamide—CYP2C19—Arachidonic acid metabolism—GGT1—hepatitis B	0.000369	0.00927	CbGpPWpGaD
Nilutamide—CYP2C9—Oxidation by Cytochrome P450—CYP2A6—hepatitis B	0.000367	0.00923	CbGpPWpGaD
Nilutamide—CYP2C9—Arachidonic acid metabolism—GGT1—hepatitis B	0.000336	0.00845	CbGpPWpGaD
Nilutamide—CYP2C8—Metapathway biotransformation—AKR1B1—hepatitis B	0.000334	0.00841	CbGpPWpGaD
Nilutamide—CYP2C19—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000331	0.00832	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GGT2—hepatitis B	0.000325	0.00817	CbGpPWpGaD
Nilutamide—AR—Coregulation of Androgen receptor activity—CTNNB1—hepatitis B	0.000314	0.00788	CbGpPWpGaD
Nilutamide—CYP2C9—Phase 1 - Functionalization of compounds—CYP2A6—hepatitis B	0.000302	0.00759	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—hepatitis B	0.000302	0.00759	CbGpPWpGaD
Nilutamide—CYP2C19—Metapathway biotransformation—AKR1B1—hepatitis B	0.000298	0.0075	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—NR0B2—hepatitis B	0.000295	0.00742	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL10—hepatitis B	0.000293	0.00737	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GGT2—hepatitis B	0.00029	0.00729	CbGpPWpGaD
Nilutamide—CYP2C9—Metapathway biotransformation—AKR1B1—hepatitis B	0.000272	0.00684	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GGT2—hepatitis B	0.000265	0.00665	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—hepatitis B	0.000252	0.00635	CbGpPWpGaD
Nilutamide—AR—Regulation of nuclear SMAD2/3 signaling—CDKN1A—hepatitis B	0.000244	0.00614	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—FASLG—hepatitis B	0.000232	0.00583	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CTNNB1—hepatitis B	0.000232	0.00583	CbGpPWpGaD
Nilutamide—CYP2C19—Melatonin metabolism and effects—NFKB1—hepatitis B	0.00023	0.00579	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—CDKN1A—hepatitis B	0.000226	0.00569	CbGpPWpGaD
Nilutamide—AR—Androgen receptor signaling pathway—PTEN—hepatitis B	0.000226	0.00568	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—FAS—hepatitis B	0.000224	0.00562	CbGpPWpGaD
Nilutamide—AR—Generic Transcription Pathway—HNF4A—hepatitis B	0.000205	0.00514	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—CYP2A6—hepatitis B	0.000197	0.00495	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—CYP2A6—hepatitis B	0.000176	0.00442	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—CYP2A6—hepatitis B	0.00016	0.00403	CbGpPWpGaD
Nilutamide—CYP2C8—Biological oxidations—GGT1—hepatitis B	0.000154	0.00387	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—CTNNB1—hepatitis B	0.000152	0.00382	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—PTEN—hepatitis B	0.000148	0.00372	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—CTNNB1—hepatitis B	0.000148	0.00372	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—NFKB1—hepatitis B	0.000147	0.0037	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—NFKB1—hepatitis B	0.000144	0.00361	CbGpPWpGaD
Nilutamide—AR—Gene Expression—NR0B2—hepatitis B	0.000142	0.00357	CbGpPWpGaD
Nilutamide—CYP2C19—Biological oxidations—GGT1—hepatitis B	0.000137	0.00345	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.00013	0.00327	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—hepatitis B	0.000126	0.00316	CbGpPWpGaD
Nilutamide—CYP2C9—Biological oxidations—GGT1—hepatitis B	0.000125	0.00315	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—CDKN1A—hepatitis B	0.000123	0.00309	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—PTEN—hepatitis B	0.000123	0.00308	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—NFKB1—hepatitis B	0.000122	0.00307	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000116	0.00292	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—TNF—hepatitis B	0.000112	0.00281	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—hepatitis B	0.000106	0.00266	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TGFB1—hepatitis B	0.000102	0.00256	CbGpPWpGaD
Nilutamide—AR—Integrated Breast Cancer Pathway—TP53—hepatitis B	0.000101	0.00254	CbGpPWpGaD
Nilutamide—AR—Gene Expression—HNF4A—hepatitis B	9.85e-05	0.00248	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TNF—hepatitis B	9.49e-05	0.00239	CbGpPWpGaD
Nilutamide—AR—SIDS Susceptibility Pathways—IL6—hepatitis B	9.01e-05	0.00226	CbGpPWpGaD
Nilutamide—AR—Integrated Pancreatic Cancer Pathway—TP53—hepatitis B	8.37e-05	0.0021	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.9e-05	0.00148	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—AKR1B1—hepatitis B	5.8e-05	0.00146	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GGT2—hepatitis B	5.56e-05	0.0014	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	5.27e-05	0.00132	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—AKR1B1—hepatitis B	5.18e-05	0.0013	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GGT2—hepatitis B	4.96e-05	0.00125	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—GGT1—hepatitis B	4.8e-05	0.00121	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—AKR1B1—hepatitis B	4.72e-05	0.00119	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GGT2—hepatitis B	4.52e-05	0.00114	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—CYP2A6—hepatitis B	3.37e-05	0.000847	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—hepatitis B	3.14e-05	0.000789	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT2—hepatitis B	3.05e-05	0.000766	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—CYP2A6—hepatitis B	3.01e-05	0.000756	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.8e-05	0.000705	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—CYP2A6—hepatitis B	2.74e-05	0.000689	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT2—hepatitis B	2.72e-05	0.000683	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GGT1—hepatitis B	2.63e-05	0.000661	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—GOT1—hepatitis B	2.63e-05	0.000661	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—ALB—hepatitis B	2.56e-05	0.000643	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT2—hepatitis B	2.48e-05	0.000623	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.4e-05	0.000602	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GOT1—hepatitis B	2.35e-05	0.00059	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—GGT1—hepatitis B	2.35e-05	0.00059	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GGT1—hepatitis B	2.14e-05	0.000538	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—GOT1—hepatitis B	2.14e-05	0.000538	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	2.14e-05	0.000538	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—hepatitis B	1.95e-05	0.00049	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—ALB—hepatitis B	1.4e-05	0.000352	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—ALB—hepatitis B	1.25e-05	0.000314	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—ALB—hepatitis B	1.14e-05	0.000286	CbGpPWpGaD
Nilutamide—CYP2C8—Metabolism—PTEN—hepatitis B	1.07e-05	0.000268	CbGpPWpGaD
Nilutamide—CYP2C19—Metabolism—PTEN—hepatitis B	9.52e-06	0.000239	CbGpPWpGaD
Nilutamide—CYP2C9—Metabolism—PTEN—hepatitis B	8.68e-06	0.000218	CbGpPWpGaD
